DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Reinshagen M, Schütz E, Armstrong VW. et al
6-thioguanine nucleotide-adapted azathioprine therapy does not lead to higher remission rates than standard therapy in chronic active crohn disease: results from a randomized, controlled, open trial.
Clinical Chemistry 2007; 53: 1306-1314
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.